TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Sanjay Jain, MD, PhD

Beth Israel Deaconess Medical Center


Boston, Massachusetts - 02215
  • CLINICAL TRIALS 4
  • CONDITIONS6
  • INTERVENTIONS6
  • SINCE2007
RAD001 in Advanced Hepatocellular Carcinoma

August 2007 - August 2010
Cetuximab 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

January 2008 - April 2011
RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors

May 2008 - December 2010
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

October 2008 - December 2010
Carcinoma

Carcinoma, Hepatocellular

Rectal Neoplasms

Neuroendocrine Tumors

Carcinoid Tumor

Adenoma, Islet Cell

Temozolomide

Rad001

Cetuximab

5-Fluorouracil

External Beam Pelvis Radiation Therapy

Som230

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo